Inflationary storm clouds will continue to buffet global pharma industry in 2023
Pharmaceutical Technology
JANUARY 16, 2023
Pharma may have to navigate a difficult path through relatively slow-to-fall inflation in regions outside the US. Untamed inflation is a top concern for the pharmaceutical industry globally in 2023. The resulting reduced profit margins could lead to further supply chain constraints of some loss-making products in certain markets.
Let's personalize your content